Surgical Innovations Group Plc (SUN) - Financial and Strategic SWOT Analysis Review

Document Sample
Surgical Innovations Group Plc (SUN) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					          Surgical Innovations Group Plc (SUN) - Financial and Strategic SWOT
                                   Analysis Review
        Reference Code: GDME21691FSA                                                                                          Publication Date: JUN 2013

          Clayton Wood House, 6 Clayton Wood
                                                             Phone              +44 113 2307597                 Revenue          7.64 (million GBP)
          Bank
          Leeds                                              Fax                +44 113 2307598                 Net Profit       0.69 (million GBP)
          LS16 6QZ                                           Website            www.surginno.com                Employees        104
                                                                                SUN     [SEATS        (AIM
          United Kingdom                                     Exchange                                           Industry         Medical Equipment
                                                                                Market)]

       Company Overview
       Surgical Innovations Group plc (SI) is a holding company that offers medical devices. It designs, develops, manufactures and
       markets medical devices for use in minimally invasive surgery (MIS) and autologous blood transfusion. The major products of the
       company include flexible endoscopic instrumentation, endoscopic clamping system, reusable laparoscopic instrument system,
       resposable flexible endoscopic instrumentation, single use laparoscopic instrument system and laparoscopic port access system.
       Its products are sold through a network of independent healthcare distributors, suppliers of medical equipment and original
       equipment manufacturers (OEM).
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Surgical Innovations Group Plc, SWOT Analysis
         N. Graham Bowland                   Chief Executive Officer                  Strengths                              Weaknesses
         Ray Simkins                         Director
                                                                                      Product Portfolio                      Weak Financial Performance
         Colin Glass                         Director
                                                                                      Industry Recognitions
         Douglas B. Liversidge               Chairman
         Mike McMahon                        Director
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                          Threats
        Research, GlobalData
                                                                                      Growing Aged Population                Competitive Landscape
       Share Data
                                                                                      Market Growth in Emerging              Rapid Technological Change
         Surgical Innovations Group Plc
                                                                                      Economies
        Share Price (GBP) as on 21-Jun-                                  0.05
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (GBP)                                                         NA         GlobalData
        Market Cap (million GBP)                                           21
        Enterprise Value (million GBP)                                     24
        Shares Outstanding (million)                                     405
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Jun 10, 2013         Surgical Innovations Successfully Concludes
                                                                                                           Pilot Testing Of Prototype Port Access
                                                                                                           Products For Hip Arthroscopy On Cadaver
                                                                                      May 31, 2012         Surgical Innovations Appoints Mike Thornton
                                                                                                           As CFO
                                                                                      May 31, 2012         Surgical  Innovations   Signs    Distribution
                                                                                                           Agreement With Elemental Healthcare
                                                                                      Mar 15, 2012         Surgical Innovations Receives FDA 510(K)
                                                                                                           Clearance For Logic Range Of Reusable
       Source: Annual Report, Company Website, Primary and Secondary
                                                                                                           Instruments
       Research, GlobalData                                                          Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




Surgical Innovations Group Plc (SUN) - Financial and Strategic                                                                 Reference Code: GDME21691FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Surgical Innovations Group Plc - Key Facts ....................................................................................................................................... 5
       Surgical Innovations Group Plc - Key Employees .............................................................................................................................. 6
       Surgical Innovations Group Plc - Key Employee Biographies ............................................................................................................ 7
       Surgical Innovations Group Plc - Key Operational Employees ........................................................................................................... 8
       Surgical Innovations Group Plc - Major Products and Services ......................................................................................................... 9
       Surgical Innovations Group Plc - History .......................................................................................................................................... 10
       Surgical Innovations Group Plc - Company Statement .................................................................................................................... 12
       Surgical Innovations Group Plc - Locations And Subsidiaries .......................................................................................................... 14
          Head Office ................................................................................................................................................................................... 14
       Surgical Innovations Group Plc - Key Manufacturing Facilities ........................................................................................................ 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       Surgical Innovations Group Plc - Business Description.................................................................................................................... 16
       Surgical Innovations Group Plc - Corporate Strategy ....................................................................................................................... 17
       Surgical Innovations Group Plc - SWOT Analysis ............................................................................................................................ 18
          SWOT Analysis - Overview........................................................................................................................................................... 18
          Surgical Innovations Group Plc - Strengths .................................................................................................................................. 18
             Strength - Product Portfolio ....................................................................................................................................................... 18
             Strength - Industry Recognitions ............................................................................................................................................... 18
             Strength - Strong Geographical Presence................................................................................................................................. 18
          Surgical Innovations Group Plc - Weaknesses ............................................................................................................................. 19
             Weakness - Weak Financial Performance ................................................................................................................................ 19
          Surgical Innovations Group Plc - Opportunities ............................................................................................................................ 19
             Opportunity - Growing Aged Population .................................................................................................................................... 19
             Opportunity - Market Growth in Emerging Economies .............................................................................................................. 19
             Opportunity - Strategic Contracts .............................................................................................................................................. 19
             Opportunity - Product Approvals ............................................................................................................................................... 20
          Surgical Innovations Group Plc - Threats ..................................................................................................................................... 20
             Threat - Competitive Landscape ............................................................................................................................................... 20
             Threat - Rapid Technological Change ....................................................................................................................................... 20
             Threat - Stringent Regulations .................................................................................................................................................. 20
       Surgical Innovations Group Plc - Key Competitors........................................................................................................................... 21
       Section 3 – Company Financial Ratios ............................................................................................................................................. 22
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 22
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 22
       Performance Chart ........................................................................................................................................................................... 24
       Financial Performance...................................................................................................................................................................... 24
       Financial Ratios - Interim Ratios....................................................................................................................................................... 25
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 26
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 27
          Surgical Innovations Group Plc, Medical Equipment, Deals By Year, 2007 to YTD 2013............................................................. 27
          Surgical Innovations Group Plc, Medical Equipment, Deals By Type, 2007 to YTD 2013 .................................
				
DOCUMENT INFO
Description: Surgical Innovations Group Plc (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Surgical Innovations Group plc (SI) is a holding company that offers medical devices.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.